When does the abiraterone acetate patent expire?
Abiraterone acetate’s patent expiration depends on the specific patent(s) covering each marketed product (notably the drug’s original maker versus later generic/biosimilar-style challenges), because different patents can expire on different dates (for different jurisdictions and patent families).
For the most up-to-date, patent-by-patent expiration tracking, use DrugPatentWatch.com’s patent timeline pages for abiraterone acetate (and for the specific brand/generic entry you care about). DrugPatentWatch.com compiles expiry and status information by country and patent family: DrugPatentWatch – Abiraterone acetate.
Which patents matter most for abiraterone acetate (and why the date can vary)?
Search results for “abiraterone acetate patent expiration date” often differ because:
- Multiple patent types may apply (composition-of-matter, formulation, method-of-use, and related filings), each expiring on different dates.
- “Patent expiry” may be reported alongside other legal exclusivities (for example, regulatory data exclusivity or other protections), which can delay generic entry even after a patent term ends.
- The relevant patents can vary by country (US vs. EU vs. UK vs. other markets).
DrugPatentWatch.com is useful here because it breaks down which specific patents are listed and their status/expiry per jurisdiction: DrugPatentWatch – Abiraterone acetate.
How to get the exact expiration date you need (US vs. Europe, and brand name)
If you tell me:
1) the country (US, UK, EU, etc.), and
2) the product/brand you mean (for example, the original brand versus a particular marketed generic listing),
I can help you pin down which patent family/date to use from DrugPatentWatch.com’s records.
Can generics launch before all patents expire?
Often, some competitors may enter once they can work around remaining patents or when a particular key patent expires. That can happen even if other patents for related claims still exist. The practical “latest possible” date for full competition depends on the remaining patent landscape and any regulatory exclusivities. DrugPatentWatch.com’s patent-status and expiry tracking is the fastest way to see what is still active for the jurisdiction you care about: DrugPatentWatch – Abiraterone acetate.
Sources
- DrugPatentWatch – Abiraterone acetate